Genentech

Phesgo

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / Phesgo – J9316

Manufacturer:

Genentech

Name:

Phesgo

HCPCS Code Descriptor:

Injection, pertuzumab, trastuzumab, and hyaluronidase-zzxf, per 10 mg

Category:

J Code

HCPCS:

J9316

NDC(s):

50242-0260-01, 50242-0245-01

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Route of Administration:

Subcutaneous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About:

Phesgo is an Oncology drug manufactured by Genentech and administered via the Subcutaneous route of administration. The J Code: J9316 is aligned to the drug Phesgo.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

1/1/21

HCPCS Effective Date:

1/1/21

HCPCS Short Description:

Pertuzu, trastuzu, 10 mg

Billing and Coding Guide:

https://www.phesgo-hcp.com/content/dam/gene/phesgo-hcp/pdfs/phesgo-coding-and-reimbursement-guide.pdf

Patient Assistance:

https://www.gene.com/patients/patient-foundation

Phesgo - J9316